MUTATIONAL ANALYSIS AND AN ALTERNATIVELY SPLICED PRODUCT OF B7 DEFINES ITS CD28/CTLA4-BINDING SITE ON IMMUNOGLOBULIN C-LIKE DOMAIN

被引:54
作者
GUO, Y
WU, Y
ZHAO, M
KONG, XP
LIU, Y
机构
[1] NYU, MED CTR, DEPT PATHOL, MICHAEL HEIDELBERGER DIV IMMUNOL, NEW YORK, NY 10016 USA
[2] NYU, MED CTR, KAPLAN COMPREHENS CANC CTR, NEW YORK, NY 10016 USA
[3] NYU, MED CTR, SKIRBALL INST BIOMOLEC RES, NEW YORK, NY 10016 USA
关键词
D O I
10.1084/jem.181.4.1345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Costimulatory molecules B7 and B7-2 interact with T cell surface receptors CD28/CTLA4 and deliver a costimulatory signal essential for T cell growth. However, the structure basis of this interaction is not known. B7 and B7-2 are members of immunoglobulin (Ig) superfamily and their extracellular portion consists of an IgV- and IgC-like domain. Here we report that a naturally occurring, alternatively spliced form of B7 reveals that exon 3-encoded IgC domain is essential for CD28/CTLA4 binding. Mutational analysis of B7 demonstrates a critical role of several amino acids around loops between strands B and C and D and E, for binding CTLA4/CD28. These amino acids are clustered to form a single binding site centered at 201Y. A comparison of the effects of mutations on the binding of CD28 and CTLA4 reveals that CD28 and CTLA4 binds to the same site on B7. These results have important implications on the role of CTLA4 and CD28 in T cell costimulation. The structure of the CD28/CTLA4-binding site also provides valuable information for immune intervention targeted at the B7/B7-2-CD28/CTLA4 interactions.
引用
收藏
页码:1345 / 1355
页数:11
相关论文
共 49 条
[1]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[2]   CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[3]  
Brestcher P, 1970, SCIENCE, V169, P1042
[4]  
BRUCE J, 1981, J IMMUNOL, V127, P2496
[5]   IN-VITRO INDUCTION OF T-CELL ANERGY BY BLOCKING B7 AND EARLY T-CELL COSTIMULATORY MOLECULE ETC-1 B7-2 [J].
CHEN, CY ;
NABAVI, N .
IMMUNITY, 1994, 1 (02) :147-154
[6]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[7]  
DAMLE NK, 1994, J IMMUNOL, V152, P2686
[8]   VASCULAR CELL-ADHESION MOLECULE-1 INDUCES T-CELL ANTIGEN RECEPTOR-DEPENDENT ACTIVATION OF CD4+ LYMPHOCYTES-T [J].
DAMLE, NK ;
ARUFFO, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6403-6407
[9]  
FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
[10]   UNCOVERING OF FUNCTIONAL ALTERNATIVE CTLA-4 COUNTER-RECEPTOR IN B7-DEFICIENT MICE [J].
FREEMAN, GJ ;
BORRIELLO, F ;
HODES, RJ ;
REISER, H ;
HATHCOCK, KS ;
LASZLO, G ;
MCKNIGHT, AJ ;
KIM, J ;
DU, LN ;
LOMBARD, DB ;
GRAY, GS ;
NADLER, LM ;
SHARPE, AH .
SCIENCE, 1993, 262 (5135) :907-909